← Back to Search

Other

Intra-Articular hip injection of PRP for Acetabular Labrum Tear (PRP for ALT Trial)

N/A

Recruiting

Led By Dan Cushman, MD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PRP for ALT Trial Summary

This trial is looking at whether injecting platelet-rich plasma from a patient's blood can help relieve hip pain and improve hip function caused by tears in the labrum. Participants will need to complete surveys and

Who is the study for?

This trial is for individuals experiencing hip pain due to acetabular labral tears, which is damage to the cartilage in the hip joint. Participants must be willing to complete surveys and undergo medical tests through various communication methods like email, text, in person or phone.Check my eligibility

What is being tested?

The study is testing Platelet-Rich Plasma (PRP) therapy on patients with acetabular labral tears. PRP involves using a concentration of platelets from the patient's own blood to potentially heal tissue and reduce pain.See study design

What are the potential side effects?

Possible side effects of PRP may include pain at the injection site, infection, tissue damage, or no improvement in hip function. However, since it uses the patient's own blood components, risks are generally considered low.

PRP for ALT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain & Function Improvements

Secondary outcome measures

EQ-5D (EuroQual 5D)

Harris Hip Scores (HHS)

International Hip Outcome Tool (iHOT-12)

+1 more

PRP for ALT Trial Design

1Treatment groups

Experimental Treatment

Group I: Intra-Articular hip injection of PRPExperimental Treatment1 Intervention

Single Group Assignment Recruitment will occur at the University of Utah Orthopedic Center by physician and study staff members medical chart review before patient visits. 45 mL of blood will be collected from eligible participants and processed. A single processed neutrophil-poor PRP injection will be given once to a single hip.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PRP

2014

Completed Phase 4

~1860

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,100 Previous Clinical Trials

1,778,871 Total Patients Enrolled

Dan Cushman, MDPrincipal InvestigatorUniversity of Utah

1 Previous Clinical Trials

10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical trial currently accepting new participants?

"According to the details on clinicaltrials.gov, this research is currently in search of eligible participants. The trial was initially listed on 1/25/2024 and most recently revised on 3/25/2024."

Answered by AI

Which individuals are eligible to participate in this research investigation?

"Individuals aged between 18 and 40 with a confirmed diagnosis of acetabular labrum tear are eligible to enroll in this study, which aims to recruit approximately 30 participants."

Answered by AI

Is the clinical trial open to participants younger than 55 years of age?

"Individuals aged between 18 and 40 years are eligible for participation in this research trial as per the inclusion criteria."

Answered by AI

What is the current number of individuals being recruited to participate in this clinical trial?

"Affirmative. Information available on clinicaltrials.gov implies that this investigation is actively seeking participants. Initially shared on January 25, 2024, and last revised on March 25, 2024, the trial aims to recruit a total of 30 patients from one designated site."

Answered by AI

Recent research and studies

Current Reviews in Musculoskeletal MedicineJournal

A Comprehensive Review of Hip Labral Tears

Groh, Megan M., and Joseph Herrera. 2009. “A Comprehensive Review of Hip Labral Tears”. Current Reviews in Musculoskeletal Medicine. Springer Science and Business Media LLC. doi:10.1007/s12178-009-9052-9.

clinicaltrials.govStudy

Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears

Daniel Cushman 2024. "Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06332352.